LTK and cancer: identified the CLIP1-LTK fusion protein as a lung cancer driver, accounting for 0.4% of cases, and demonstrated that LTK rearrangements, identified using fluorescent probes targeting the 5’ and 3’ ends of LTK, were present in 18% of cancer cells, forming the CLIP1-LTK fusion protein.